Protillion Biosciences Partners With Merck on AI Drug Discovery
CARLSBAD, Calif., June 16, 2026 Protillion Biosciences has announced a significant multi-target drug discovery collaboration and license agreement with...
ADC AI drug discovery artificial intelligence Autoimmune Disease biologics Biomarkers biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery FDA fda approval FDA clearance Gene Therapy healthcare technology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine targeted therapy
CARLSBAD, Calif., June 16, 2026 Protillion Biosciences has announced a significant multi-target drug discovery collaboration and license agreement with...
DUBLIN, Ireland and VANCOUVER, British Columbia, June 17, 2026 Jazz Pharmaceuticals and AbCellera have announced a major strategic collaboration...
GOTHENBURG, Sweden | January 19, 2026 — IRLAB Therapeutics AB, a clinical-stage company focused on novel treatments for Parkinson’s...
